PHARMACOKINETICS OF TOTAL AND FREE VALPROIC ACID DURING MONOTHERAPY IN INFANTS

被引:13
|
作者
HERNGREN, L [1 ]
LUNDBERG, B [1 ]
NERGARDH, A [1 ]
机构
[1] KAROLINSKA HOSP,DEPT PAEDIAT,S-10401 STOCKHOLM 60,SWEDEN
关键词
VALPROIC ACID; INFANTS; PROTEIN BINDING; PHARMACOKINETICS;
D O I
10.1007/BF00315328
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The pharmacokinetics of free and total valproic acid (VPA) in plasma and whole blood after oral administration during steady state was investigated in seven infants (mean age 10.7 months) receiving monotherapy. The VPA concentrations in whole blood closely followed those in plasma but at a reduced level. A positive correlation was found between dose and mean plasma concentration (r = 0.71). Mean terminal half-lives were similar in plasma and whole blood (12.5 and 15.5 h, respectively), but were considerably longer than for free VPA (6.4 and 6.5 h, respectively; P < 0.01). There was a significant decrease in half-lives with increasing age (P < 0.05). Plasma and whole blood clearance for total VPA was higher than reported in older infants and adults (17.8 and 28.9 ml/kg per hour) and was considerably higher for free VPA (127.6 and 188.8 ml/kg per hour, respectively). The increase in clearance compared with that in older subjects is well in concordance with a lower protein binding of VPA (mean 85.3%). Of special importance is that the percentage of unbound VPA increased with increasing concentrations of total VPA. The fraction of unbound VPA in plasma increased even more in subjects with low albumin concentrations (P < 0.01).
引用
收藏
页码:315 / 319
页数:5
相关论文
共 50 条
  • [41] A systematic review of population pharmacokinetics of valproic acid
    Methaneethorn, Janthima
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (05) : 816 - 834
  • [42] DUAL EFFECT OF VALPROIC ACID ON THE PHARMACOKINETICS OF PHENYTOIN
    LAI, ML
    HUANG, JD
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1993, 14 (04) : 365 - 370
  • [43] EVALUATION OF VALPROIC ACID EMBRYOTOXICITY AND PHARMACOKINETICS IN THE RAT
    BINKERD, PB
    ROWLAND, JM
    NAU, H
    BRACCO, C
    HENDRICKX, AG
    TERATOLOGY, 1987, 35 (02) : A28 - A29
  • [44] EFFECTS OF SALICYLATE ON PHARMACOKINETICS OF VALPROIC ACID IN RATS
    YU, HY
    SHEN, YZ
    SUGIYAMA, Y
    HANANO, M
    DRUG METABOLISM AND DISPOSITION, 1990, 18 (01) : 121 - 126
  • [45] EFFECT OF AMOXICILLIN/CLAVULANATE ON THE PHARMACOKINETICS OF VALPROIC ACID
    Lee, S. Y.
    Jung, J. A.
    Kim, J. R.
    Huh, W. S.
    Ko, J. W.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E26 - E26
  • [46] Circadian variation of Valproic acid pharmacokinetics in mice
    Ben-Cherif, Wafa
    Dridi, Ichrak
    Aouam, Karim
    Ben-Attia, Mossadok
    Reinberg, Alain
    Boughattas, Naceur A.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 49 (04) : 468 - 473
  • [47] COMPARISON OF STEADY-STATE PHARMACOKINETICS OF VALPROIC ACID IN CHILDREN BETWEEN MONOTHERAPY AND MULTIPLE ANTIEPILEPTIC DRUG-TREATMENT
    CHIBA, K
    SUGANUMA, T
    ISHIZAKI, T
    IRIKI, T
    SHIRAI, Y
    NAITOH, H
    HORI, M
    JOURNAL OF PEDIATRICS, 1985, 106 (04): : 653 - 658
  • [48] INITIAL MONOTHERAPY WITH CARBAMAZEPINE, VALPROIC ACID, AND TOPIRAMATE: RETROSPECTIVE STUDY
    Kim, J. M.
    Oh, G. S.
    Lee, G. H.
    Lee, S. H.
    Park, H. K.
    Lee, S. B.
    Yi, S. D.
    Park, S. H.
    EPILEPSIA, 2009, 50 : 31 - 32
  • [49] Low serum biotinidase activity in children with valproic acid monotherapy
    Schulpis, KH
    Karikas, GA
    Tjamouranis, J
    Regoutas, S
    Tsakiris, S
    EPILEPSIA, 2001, 42 (10) : 1359 - 1362
  • [50] Valproic Acid Monotherapy in Pregnancy and Major Congenital Malformations.
    Jentink, Janneke
    Loane, Maria A.
    Dolk, Helen
    Barisic, Ingeborg
    Garne, Ester
    Morris, Joan K.
    de Jong-van den Berg, Lolkje T. W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (23): : 2185 - 2193